Almost every quantitative error in an RNA experiment is introduced before the thermocycler ever closes its lid. RT-qPCR is routinely treated as a simple two-step kit protocol, but the reverse-transcription reaction is a fresh enzymatic conversion with its own efficiency, its own inhibitors, and its own sequence bias. This post deliberately complements the existing general PCR/qPCR article on this site: here the focus is the step that makes RNA measurable at all.
What reverse transcription actually does
Reverse transcriptase copies an RNA template into complementary DNA using a primer that anneals to the RNA. Three enzyme families dominate: AMV RT, the more thermostable MMLV variants (SuperScript, Maxima), and engineered enzymes with reduced RNase H activity. RNase H activity matters because it degrades the RNA strand of the RNA:DNA hybrid; enzymes with reduced activity generally give longer, more complete cDNA, especially for long or structured templates.
Three priming strategies exist, and the choice is consequential:
- Oligo(dT) primes from the poly(A) tail — excellent for eukaryotic mRNA, poor for prokaryotic RNA, degraded RNA, and non-polyadenylated transcripts.
- Random hexamers prime everywhere, giving the most even coverage and tolerance of fragmentation, but they also transcribe ribosomal and other abundant RNA, diluting the signal.
- Gene-specific primers give the highest specificity for a single target but cannot be reused across a panel.
A mixture of oligo(dT) and random hexamers is a common compromise. Whatever the choice, the same priming strategy must be used across all samples and conditions — switching mid-experiment invalidates any comparison.
One-step versus two-step formats
In one-step RT-qPCR, reverse transcription and amplification occur in a single tube with a single buffer. This reduces pipetting error and contamination risk, and is the standard for diagnostics and for high-throughput screening. Its weaknesses are that the RT and polymerase enzymes must tolerate shared buffer conditions, and that cDNA cannot be archived or re-queried for other genes.
Two-step formats separate the reactions, which lets you dilute the RT reaction away from its inhibitors and reuse the cDNA for dozens of targets. For research panels where several genes are measured from the same sample, two-step is usually the right call. I generally prepare a cDNA batch once and freeze aliquots, avoiding repeated freeze–thaw cycles of the RNA.
SYBR versus probe chemistry
SYBR Green intercalates into any double-stranded DNA, so its fluorescence reports total product accumulation regardless of identity. That makes it cheap, universally applicable, and dependent on melt-curve analysis for correctness. Probe-based chemistry (TaqMan, hydrolysis probes, molecular beacons) adds a sequence-specific fluorescent oligonucleotide, so fluorescence is emitted only when the correct amplicon is formed. Probes cost more and require careful design, but they permit multiplexing and tolerate primer–dimer far better.
My rule: use SYBR for initial screening and modest target numbers where a melt curve is inspected every run; use probes for diagnostics, multiplexing, and any assay where the amplicon cannot be verified by melt profile — short amplicons in particular have poorly separated melt peaks.
Primer design: exon-spanning is not optional
The single most valuable design rule in RT-qPCR is to place one primer (or the probe) across an exon–exon junction so that genomic DNA cannot be amplified, or to place primers in two different exons separated by a large intron. This reliably distinguishes cDNA from genomic contamination. The amplicon should be short — 70 to 150 bp is the sweet spot — because reverse transcription rarely produces full-length cDNA and long amplicons under-report abundance.
- GC content 40–60%, melting temperatures matched within 1–2 °C.
- Avoid runs of four or more identical bases and guanine-rich 3′ or 5′ ends.
- BLAST every primer pair against the transcriptome and genome to confirm specificity.
- Always run a no-RT (−RT) control per sample: an amplicon there means DNA contamination, not biology.
Absolute quantification via standard curves
Absolute quantification asks how many molecules are present. It requires a standard curve built from known quantities of a template — either a purified amplicon, a plasmid dilution series, or synthetic RNA — run on the same plate as the samples. The quantification cycle (Cq) is plotted against log10(copies), and the unknown is interpolated. A competent standard curve has a slope between −3.1 and −3.6 (efficiency 90–110%) and R² above 0.99.
Plate-to-plate variation in Cq is real and often larger than the biological effect you are chasing, so standards must be on every plate, never carried over from a previous run. This is the price of absolute numbers, and it is why relative quantification dominates most research labs.
Relative quantification: ΔΔCt and efficiency correction
The comparative Ct (ΔΔCt) method expresses each target relative to a reference gene and a control sample:
- ΔCt = Cq(target) − Cq(reference) for each sample.
- ΔΔCt = ΔCt(sample) − ΔCt(control group mean).
- Fold change = 2−ΔΔCt, valid only when efficiencies approximate 100% and are equal between target and reference.
When efficiencies differ, the Pfaffl method corrects for them explicitly and is the safer choice. Reference-gene validity is the other half of the problem: no single housekeeping gene is stable across all conditions. GAPDH varies with glycolysis and hypoxia, ACTB with cytoskeletal state, and 18S rRNA is transcribed by a different polymerase and correlates poorly with mRNA content. Use at least two references, and verify stability with a tool such as geNorm or NormFinder rather than assuming it.
What RT-qPCR tells you, and what it does not
RT-qPCR measures the abundance of a sequence, not the amount of functional protein. A two-fold change in transcript may be invisible at the protein level, and miRNA-mediated translational repression produces large protein changes with minimal mRNA changes. Correlation between mRNA and protein in single cells is famously weak. Report RT-qPCR as transcript-level evidence and pair it with western blot or proteomics when the biological claim concerns protein.
Finally, respect the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines: report RNA integrity, RT enzyme and priming strategy, primer sequences and amplicon length, efficiency, reference genes and their validation, and the number of technical and biological replicates. Most irreproducible expression data in the literature violate at least one of these, and reviewers increasingly check.
References
- Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–622.
- Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
- Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
- Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–5250.
- Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3):1559–1582.
- Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6(10):995–1001.
- Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6(10):986–994.
- Bustin SA, Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech. 2004;15(3):155–166.
- Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108.